Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

9480	Companies
185564	Keywords
117971	Articles
99400	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 02/19/2025 at 15:00, 9 months 14 days ago

Jaguar Receives Regulatory Clearance in Germany and Italy for Crofelemer for Rare Disease Study - Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Jaguar Health, Inc. announces initiation of clinical trial for crofelemer in rare diseases SBS-IF and MVID. First proof-of-concept results expected in H1 2025

Crofelemer Clinical Trial Jaguar Health Inc. MVID SBS-IF
BRIEF

published on 02/18/2025 at 15:05, 9 months 15 days ago

Jaguar Health étend sa collaboration pour le développement du NP-300

Santé Jaguar Traitement Du Choléra NP-300 Programme TDPRV Collaboration Pharmaceutique
BRIEF

published on 02/18/2025 at 15:05, 9 months 15 days ago

Jaguar Health Extends Collaboration for NP-300 Development

Jaguar Health Cholera Treatment NP-300 TDPRV Program Pharmaceutical Collaboration
PRESS RELEASE

published on 02/18/2025 at 15:00, 9 months 15 days ago

Jaguar Health Extends Collaboration for Possible Tropical Disease Priority Review Voucher and Cholera Indication for NP-300
Jaguar Health and Napo Pharmaceuticals extend collaboration with Streeterville related to development of NP-300 drug product candidate for cholera patients, aiming for Tropical Disease Priority Review Voucher from FDA

Napo Pharmaceuticals Jaguar Health Cholera NP-300 Tropical Disease Priority Review Voucher
BRIEF

published on 02/13/2025 at 15:10, 9 months 20 days ago

Jaguar Health participera à la conférence Emerging Growth

Lisa Conte Conférence Sur La Croissance Émergente Santé Jaguar Énoncés Prospectifs Médicaments Gastro-intestinaux
BRIEF

published on 02/13/2025 at 15:10, 9 months 20 days ago

Jaguar Health to Present at Emerging Growth Conference

Forward-looking Statements Jaguar Health Lisa Conte Emerging Growth Conference Gastrointestinal Medicines
PRESS RELEASE

published on 02/13/2025 at 15:05, 9 months 20 days ago

Jaguar Health Presenting February 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts
Jaguar Health, Inc. founder Lisa Conte to present virtually at Emerging Growth Conference on Feb 18, 2025. Company focuses on sustainable pharmaceuticals derived from rainforest plants for gastrointestinal distress

Pharmaceuticals Gastrointestinal Distress Jaguar Health Lisa Conte Emerging Growth Conference
BRIEF

published on 02/06/2025 at 16:05, 9 months 27 days ago

Magdalena Biosciences fera une présentation à la conférence des PDG et investisseurs de BIO

Santé Mentale Demande D'IND Biosciences De Magdalena Médicaments À Base De Plantes MB2500
BRIEF

published on 02/06/2025 at 16:05, 9 months 27 days ago

Magdalena Biosciences to Present at BIO CEO & Investor Conference

Mental Health Magdalena Biosciences IND Application Botanical Drugs MB2500
PRESS RELEASE

published on 02/06/2025 at 16:00, 9 months 27 days ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference
Magdalena to submit IND application for psychoactive drug candidate for mental health indications. MB2500 aims to treat cognitive deficit in schizophrenia and ADHD. Magdalena focuses on safe, plant-based drugs under FDA Botanical Guidance

Mental Health IND Application Magdalena Psychoactive Drug Cognitive Deficit

Accesswire

Published on 12/06/2025 at 02:00, 2 hours 38 minutes ago

Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 3 hours 23 minutes ago

Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 4 hours 13 minutes ago

GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 4 hours 38 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 5 hours 8 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 6 hours 22 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 6 hours 26 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 9 hours 40 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 10 hours 11 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 10 hours 22 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 5 hours 38 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 5 hours 38 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 5 hours 38 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 5 hours 38 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 11 hours 20 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE